CL2011001870A1 - Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico. - Google Patents

Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico.

Info

Publication number
CL2011001870A1
CL2011001870A1 CL2011001870A CL2011001870A CL2011001870A1 CL 2011001870 A1 CL2011001870 A1 CL 2011001870A1 CL 2011001870 A CL2011001870 A CL 2011001870A CL 2011001870 A CL2011001870 A CL 2011001870A CL 2011001870 A1 CL2011001870 A1 CL 2011001870A1
Authority
CL
Chile
Prior art keywords
compatible
fibrin
blood
gel
vehiculization
Prior art date
Application number
CL2011001870A
Other languages
English (en)
Inventor
Oppenheimer Carolina Ruth Weinstein
Gonzalez Donald Irving Brown
Chandia Miguel Angel Fuentes
Fernandez Ricar Ceriani
Original Assignee
U Tecnica Federico Santa Maria 28 71%
U De Valparaiso 38%
U De Playa Ancha 4 86%
Inst De Seguridad De Trabajo 23 38%
Neos Ltda 5 05%
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U Tecnica Federico Santa Maria 28 71%, U De Valparaiso 38%, U De Playa Ancha 4 86%, Inst De Seguridad De Trabajo 23 38%, Neos Ltda 5 05% filed Critical U Tecnica Federico Santa Maria 28 71%
Priority to CL2011001870A priority Critical patent/CL2011001870A1/es
Publication of CL2011001870A1 publication Critical patent/CL2011001870A1/es
Priority to US14/235,909 priority patent/US20140242181A1/en
Priority to BR112014002628A priority patent/BR112014002628A2/pt
Priority to PE2014000136A priority patent/PE20141248A1/es
Priority to PCT/CL2012/000039 priority patent/WO2013016836A1/es
Priority to JP2014523156A priority patent/JP2014524269A/ja
Priority to EP12819721.7A priority patent/EP2740443A4/en
Priority to CO14016785A priority patent/CO7020845A2/es
Priority to IL230762A priority patent/IL230762A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/10—Hair or skin implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/10—Hair or skin implants
    • A61F2/105—Skin implants, e.g. artificial skin
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2270/00—Control; Monitoring or safety arrangements
    • F04C2270/04—Force
    • F04C2270/042—Force radial
    • F04C2270/0421—Controlled or regulated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Proceso de preparación de un gel de fibrina autólogo o desde sangre compatible para proliferación y vehiculización celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirúrgico.
CL2011001870A 2011-08-03 2011-08-03 Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico. CL2011001870A1 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CL2011001870A CL2011001870A1 (es) 2011-08-03 2011-08-03 Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico.
US14/235,909 US20140242181A1 (en) 2011-08-03 2012-08-03 Preparation of fibrin gel for use as implant system
BR112014002628A BR112014002628A2 (pt) 2011-08-03 2012-08-03 processo para a preparação de um gel de fibrina, gel de fibrina e uso do gel de fibrina
PE2014000136A PE20141248A1 (es) 2011-08-03 2012-08-03 Procedimiento para la preparacion de un sistema de implante autologo y sistema de implante asi obtenido
PCT/CL2012/000039 WO2013016836A1 (es) 2011-08-03 2012-08-03 Preparación de gel de fibrina útil como sistema de implante.
JP2014523156A JP2014524269A (ja) 2011-08-03 2012-08-03 自己移植システムの調製方法およびこれにより得られた移植システム
EP12819721.7A EP2740443A4 (en) 2011-08-03 2012-08-03 PREPARATION OF FIBRINGEL FOR USE AS IMPLANT SYSTEM
CO14016785A CO7020845A2 (es) 2011-08-03 2014-01-28 Procedimiento para la preparación de un sistema de implante autólogo y sistema de implante así obtenido
IL230762A IL230762A0 (en) 2011-08-03 2014-02-02 A method for preparing an implant system originating from a patient and an implant system thus obtained

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2011001870A CL2011001870A1 (es) 2011-08-03 2011-08-03 Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico.

Publications (1)

Publication Number Publication Date
CL2011001870A1 true CL2011001870A1 (es) 2012-01-27

Family

ID=50436515

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011001870A CL2011001870A1 (es) 2011-08-03 2011-08-03 Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico.

Country Status (9)

Country Link
US (1) US20140242181A1 (es)
EP (1) EP2740443A4 (es)
JP (1) JP2014524269A (es)
BR (1) BR112014002628A2 (es)
CL (1) CL2011001870A1 (es)
CO (1) CO7020845A2 (es)
IL (1) IL230762A0 (es)
PE (1) PE20141248A1 (es)
WO (1) WO2013016836A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107004902B (zh) 2014-10-02 2021-02-02 塞勒创尼克斯公司 具有增强的电化学和热稳定性的含有机硅的电解液组合物
EP3285575B1 (en) 2015-04-23 2019-08-14 Bone Therapeutics S.A. In vitro preservation of therapeutic cells
WO2017066822A1 (en) * 2015-10-19 2017-04-27 Skin Tissue Engineering Pty Ltd Porous matrix with incorporated cells
RU2758260C1 (ru) * 2020-12-24 2021-10-27 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний" (НИИ КПССЗ) Способ изготовления аутологичного фибрина с регулируемым содержанием фибриногена без использования экзогенного тромбина

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185001A (en) 1990-01-18 1993-02-09 The Research Foundation Of State University Of New York Method of preparing autologous plasma fibrin and application apparatus therefor
US5674394A (en) 1995-03-24 1997-10-07 Johnson & Johnson Medical, Inc. Single use system for preparation of autologous plasma
US5643192A (en) 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
WO2000062828A1 (en) 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
WO1997040864A1 (en) 1996-04-30 1997-11-06 Medtronic, Inc. Method for making autologous fibrin sealant
IT1284550B1 (it) 1996-09-18 1998-05-21 Flavio Tarantino Procedimento per la preparazione di colla di fibrina autologa ad uso chirurgico
IT1292410B1 (it) 1997-06-24 1999-02-08 Roberto Beretta Contenitore di pronto impiego per ottenere colla di fibrina autologa
WO2007021344A1 (en) 2005-08-17 2007-02-22 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US20080199513A1 (en) 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
ES2132027B1 (es) * 1997-07-04 2000-04-01 Comunitario De Transfusion Del Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
ES2173812B1 (es) * 2001-03-01 2003-12-16 Ct Investig Energeticas Ciemat Dermis artificial y metodo de obtencion.
US8798933B2 (en) * 2008-10-31 2014-08-05 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate

Also Published As

Publication number Publication date
CO7020845A2 (es) 2014-08-11
EP2740443A4 (en) 2015-01-07
PE20141248A1 (es) 2014-10-22
US20140242181A1 (en) 2014-08-28
BR112014002628A2 (pt) 2017-08-08
WO2013016836A1 (es) 2013-02-07
IL230762A0 (en) 2014-03-31
EP2740443A1 (en) 2014-06-11
JP2014524269A (ja) 2014-09-22

Similar Documents

Publication Publication Date Title
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
DOP2017000078A (es) Indazoles sustituidos con bencilo como inhibidores de bub1.
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
EA201690617A1 (ru) Комбинирование anti-lag-3-антител и анти-pd-1-антител для лечения опухолей
ECSP14033037A (es) Síntesis de compuestos heterocíclicos
CR20130374A (es) Compuestos y métodos para la modulación de quinasas e indicaciones para los mismos
AR090017A1 (es) Agonistas de fgfr1 y sus metodos de uso
MX2019013670A (es) Formulaciones de anticuerpos y proteinas.
EA201500172A1 (ru) Модифицированные полипептиды фактора х и их применение
GT201200321A (es) Derivados de heteroaril imidazolona como inhibidores de jak
BR112013005116A2 (pt) moduladores e métodos de uso
CR20140212A (es) Anticuerpos anti-htra1 y métodos de uso
CL2013000018A1 (es) Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros.
BR112013029800A2 (pt) tratamento de degeneração do disco intervertebral com o uso de células derivadas do tecido do tecido do cordão umbilical humano
AR090923A1 (es) Anticuerpos anti-il-23
UY32918A (es) Nuevos compuestos de 2-piridona
AR079889A1 (es) Antagonistas de wnt y metodos de tratamiento y deteccion
WO2014134084A3 (en) Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy
UY34097A (es) Alineación de anticoagulante de cebado para extracción de sangre.
UY34603A (es) Anticuerpos anti-asic-1 y usos de los mismos
MX2016005824A (es) Metodo de cultivo celular.
PE20151925A1 (es) Anticuerpos anti-igf-1r con abolicion de la union al fcrn y su utilizacion en el tratamiento de enfermedades oculares vasculares
CY1123718T1 (el) Κυτταροκαλλιεργεια
BR112016028512A2 (pt) métodos de cultivo por perfusão e seu uso